Survival trends in patients with gastric and esophageal adenocarcinomas: A population-based study

Sarah J. Crane, G. Richard Locke, William S. Harmsen, Alan R. Zinsmeister, Yvonne Romero, Nicholas J. Talley

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

OBJECTIVE: To use a population-based approach to describe survival trends in patients diagnosed as having gastric or esophageal adenocarcinoma. PATIENTS AND METHODS: A population-based complete chart review of all inpatient and outpatient records, using the resources of the Rochester Epidemiology Project, was conducted in Olmsted County, Minnesota (population 124,277), a primarily rural county with one large urban area. All residents of Olmsted County who were diagnosed as having gastric or esophageal adenocarcinoma from January 1, 1971, through December 31, 2000, were included in the study. The main outcomes were median survival and 2-year and 5-year survival rates, by decade of diagnosis. RESULTS: From 1971 through 2000, median survival for patients with gastric adenocarcinoma (n=121) decreased from 5.5 months to 3.2 months, whereas median survival for patients with esophageal adenocarcinoma (n=65) increased from 8.5 months to 11.7 months. Decade of diagnosis was not significantly associated with patient survival for either gastric or esophageal adenocarcinoma (P>.05). There was no significant shift in stage of disease at diagnosis during the 30-year period for either gastric or esophageal adenocarcinoma (P>.05). CONCLUSION: No significant change has occurred in the survival rates of this patient population with gastric or esophageal adenocarcinoma, which is representative of the US white population.

Original languageEnglish (US)
Pages (from-to)1087-1094
Number of pages8
JournalMayo Clinic Proceedings
Volume83
Issue number10
DOIs
StatePublished - 2008

Fingerprint

Stomach
Adenocarcinoma
Survival
Population
Survival Rate
Inpatients
Epidemiology
Outpatients

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Crane, S. J., Locke, G. R., Harmsen, W. S., Zinsmeister, A. R., Romero, Y., & Talley, N. J. (2008). Survival trends in patients with gastric and esophageal adenocarcinomas: A population-based study. Mayo Clinic Proceedings, 83(10), 1087-1094. https://doi.org/10.4065/83.10.1087

Survival trends in patients with gastric and esophageal adenocarcinomas : A population-based study. / Crane, Sarah J.; Locke, G. Richard; Harmsen, William S.; Zinsmeister, Alan R.; Romero, Yvonne; Talley, Nicholas J.

In: Mayo Clinic Proceedings, Vol. 83, No. 10, 2008, p. 1087-1094.

Research output: Contribution to journalArticle

Crane, SJ, Locke, GR, Harmsen, WS, Zinsmeister, AR, Romero, Y & Talley, NJ 2008, 'Survival trends in patients with gastric and esophageal adenocarcinomas: A population-based study', Mayo Clinic Proceedings, vol. 83, no. 10, pp. 1087-1094. https://doi.org/10.4065/83.10.1087
Crane, Sarah J. ; Locke, G. Richard ; Harmsen, William S. ; Zinsmeister, Alan R. ; Romero, Yvonne ; Talley, Nicholas J. / Survival trends in patients with gastric and esophageal adenocarcinomas : A population-based study. In: Mayo Clinic Proceedings. 2008 ; Vol. 83, No. 10. pp. 1087-1094.
@article{c2c01997c56b449895d499948577ce09,
title = "Survival trends in patients with gastric and esophageal adenocarcinomas: A population-based study",
abstract = "OBJECTIVE: To use a population-based approach to describe survival trends in patients diagnosed as having gastric or esophageal adenocarcinoma. PATIENTS AND METHODS: A population-based complete chart review of all inpatient and outpatient records, using the resources of the Rochester Epidemiology Project, was conducted in Olmsted County, Minnesota (population 124,277), a primarily rural county with one large urban area. All residents of Olmsted County who were diagnosed as having gastric or esophageal adenocarcinoma from January 1, 1971, through December 31, 2000, were included in the study. The main outcomes were median survival and 2-year and 5-year survival rates, by decade of diagnosis. RESULTS: From 1971 through 2000, median survival for patients with gastric adenocarcinoma (n=121) decreased from 5.5 months to 3.2 months, whereas median survival for patients with esophageal adenocarcinoma (n=65) increased from 8.5 months to 11.7 months. Decade of diagnosis was not significantly associated with patient survival for either gastric or esophageal adenocarcinoma (P>.05). There was no significant shift in stage of disease at diagnosis during the 30-year period for either gastric or esophageal adenocarcinoma (P>.05). CONCLUSION: No significant change has occurred in the survival rates of this patient population with gastric or esophageal adenocarcinoma, which is representative of the US white population.",
author = "Crane, {Sarah J.} and Locke, {G. Richard} and Harmsen, {William S.} and Zinsmeister, {Alan R.} and Yvonne Romero and Talley, {Nicholas J.}",
year = "2008",
doi = "10.4065/83.10.1087",
language = "English (US)",
volume = "83",
pages = "1087--1094",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "10",

}

TY - JOUR

T1 - Survival trends in patients with gastric and esophageal adenocarcinomas

T2 - A population-based study

AU - Crane, Sarah J.

AU - Locke, G. Richard

AU - Harmsen, William S.

AU - Zinsmeister, Alan R.

AU - Romero, Yvonne

AU - Talley, Nicholas J.

PY - 2008

Y1 - 2008

N2 - OBJECTIVE: To use a population-based approach to describe survival trends in patients diagnosed as having gastric or esophageal adenocarcinoma. PATIENTS AND METHODS: A population-based complete chart review of all inpatient and outpatient records, using the resources of the Rochester Epidemiology Project, was conducted in Olmsted County, Minnesota (population 124,277), a primarily rural county with one large urban area. All residents of Olmsted County who were diagnosed as having gastric or esophageal adenocarcinoma from January 1, 1971, through December 31, 2000, were included in the study. The main outcomes were median survival and 2-year and 5-year survival rates, by decade of diagnosis. RESULTS: From 1971 through 2000, median survival for patients with gastric adenocarcinoma (n=121) decreased from 5.5 months to 3.2 months, whereas median survival for patients with esophageal adenocarcinoma (n=65) increased from 8.5 months to 11.7 months. Decade of diagnosis was not significantly associated with patient survival for either gastric or esophageal adenocarcinoma (P>.05). There was no significant shift in stage of disease at diagnosis during the 30-year period for either gastric or esophageal adenocarcinoma (P>.05). CONCLUSION: No significant change has occurred in the survival rates of this patient population with gastric or esophageal adenocarcinoma, which is representative of the US white population.

AB - OBJECTIVE: To use a population-based approach to describe survival trends in patients diagnosed as having gastric or esophageal adenocarcinoma. PATIENTS AND METHODS: A population-based complete chart review of all inpatient and outpatient records, using the resources of the Rochester Epidemiology Project, was conducted in Olmsted County, Minnesota (population 124,277), a primarily rural county with one large urban area. All residents of Olmsted County who were diagnosed as having gastric or esophageal adenocarcinoma from January 1, 1971, through December 31, 2000, were included in the study. The main outcomes were median survival and 2-year and 5-year survival rates, by decade of diagnosis. RESULTS: From 1971 through 2000, median survival for patients with gastric adenocarcinoma (n=121) decreased from 5.5 months to 3.2 months, whereas median survival for patients with esophageal adenocarcinoma (n=65) increased from 8.5 months to 11.7 months. Decade of diagnosis was not significantly associated with patient survival for either gastric or esophageal adenocarcinoma (P>.05). There was no significant shift in stage of disease at diagnosis during the 30-year period for either gastric or esophageal adenocarcinoma (P>.05). CONCLUSION: No significant change has occurred in the survival rates of this patient population with gastric or esophageal adenocarcinoma, which is representative of the US white population.

UR - http://www.scopus.com/inward/record.url?scp=54049114274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54049114274&partnerID=8YFLogxK

U2 - 10.4065/83.10.1087

DO - 10.4065/83.10.1087

M3 - Article

C2 - 18828967

AN - SCOPUS:54049114274

VL - 83

SP - 1087

EP - 1094

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 10

ER -